Advertisement

Topics

Data show positive results for AstraZeneca's late-stage trial of Lynparza

05:17 EDT 20 Mar 2017 | SmartBrief

AstraZeneca's Lynparza, or olaparib, tablets met the primary endpoint of a late-stage study in which the drug showed signific -More

Original Article: Data show positive results for AstraZeneca's late-stage trial of Lynparza

NEXT ARTICLE

More From BioPortfolio on "Data show positive results for AstraZeneca's late-stage trial of Lynparza"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...